KOPRAN
|
The Current P/S Ratio of KOPRAN is 1.22.
Share Price | ₹157.9 | Aug 13,2025 |
Market Cap | ₹762.4 Cr | |
Sales-TTM | ₹625.4 Cr | TTM-Consolidated Results |
Price/Sales | 1.22x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of KOPRAN
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹762.4 Cr] as on Aug 13,2025
(/) Sales [ ₹625.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.22x ]
Thus, for KOPRAN , the investors are currently willing to pay '1.22 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of KOPRAN !
The chart below summarizes the trend in P/S Ratio of KOPRAN over the last five years.
Historical PS (Price/Sales) ratio chart of KOPRAN
PS Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.41x.
- KOPRAN 's operated at median p/e ratio of 0.97x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/e ratio peaked in Mar2022 at 2.84x.
- KOPRAN 's p/e ratio hit its five-year low in Mar2020 of 0.3x.
How does KOPRAN 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
KOPRAN | 625.4 | 1.22 | 762.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.32 | 393,383.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 16.79 | 162,026.0 |
CIPLA LTD | 27,811.2 | 4.54 | 126,159.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.35 | 122,450.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.12 | 104,536.0 |
MANKIND PHARMA LTD | 12,956.2 | 7.85 | 101,758.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.22 | 99,521.6 |
LUPIN LTD | 23,375.9 | 3.89 | 90,856.2 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.95 | 62,561.1 |
ABBOTT INDIA LTD | 6,589.9 | 10.64 | 70,094.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KOPRAN 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.22x |
Max industry PS | 16.79x |
Median industry PS | 4.54x |
Average industry PS | 6.53x |
You may also like the below Video Courses